Surfing MASH

Driving The Discussion in MASH and Fatty Liver Disease https://surfingmash.com
Drug developers, investors, researchers, and corporate executives wrestle weekly to understand what is happening in commercial development of NASH medications. Hepatology researcher and Key Opinion Leader Dr. Stephen Harrison, Louise Campbell MSc AP., and Forecasting and Pricing guru Roger Green, M.B.A., discuss the issues affecting the evolving NASH market from their own unique perspectives on the Surfing the MASH Tsunami podcast.